Nonpersistent Nanoarchitectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck Carcinoma

A Gonnelli, M Gerbé de Thoré, ML Ermini… - Advanced …, 2024 - Wiley Online Library
… Cisplatin chemoradiotherapy (CRT) is the established standard of care for managing HPV+
head/neck carcinoma. The typically young patients may suffer serious and long-time side …

Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy

A Ohno, T Iwata, Y Katoh, S Taniguchi, K Tanaka… - Gynecologic …, 2020 - Elsevier
… In this retrospective study, intratumoral lesions in colposcopic biopsies from 55 women
with advanced cervical cancer who subsequently underwent CCRT at our institution were …

… immune-inflammation index predict needs for teeth extractions for locally advanced head and neck cancer patients undergoing concurrent chemoradiotherapy

B Yilmaz, E Somay, U Selek… - Therapeutics and Clinical …, 2021 - Taylor & Francis
… predicting the teeth caries and need for tooth extraction after concurrent chemoradiotherapy
(C-CRT) for locally advanced squamous-cell head and neck cancer (LA-SCHNC) patients. …

Prediction of early response to concurrent chemoradiotherapy in cervical cancer: value of multi-parameter MRI combined with clinical prognostic factors

X Zheng, W Guo, J Dong, L Qian - Magnetic Resonance Imaging, 2020 - Elsevier
cancer and the fourth most common cause of cancer death in women worldwide [1]. Concurrent
chemoradiotherapy … standard treatment for locally advanced cervical cancer [2]. However…

… of the MNA-SF, MUST, and NRS-2002 nutritional tools in predicting treatment incompletion of concurrent chemoradiotherapy in patients with head and neck cancer

SW Hsueh, CC Lai, CY Hung, YC Lin, CH Lu… - … Care in Cancer, 2021 - Springer
Concurrent chemoradiotherapy (CCRT) treatment incompletion is a known negative
prognosticator for patients with head and neck cancer (HNC). Malnutrition is a common …

TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer

I Kuno, D Takayanagi, Y Asami, N Murakami… - Scientific Reports, 2021 - nature.com
… with prognosis in locally advanced cervical cancer. Seventy patients diagnosed with …
cervical cancer underwent radiotherapy or concurrent chemoradiotherapy at the National Cancer

[HTML][HTML] Nutrition impact symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy

Y Wang, Q Lu, L Zhang, B Zhuang, T Zhang… - Journal of Pain and …, 2021 - Elsevier
… with head and neck cancer (HNC) worldwide in 2018. Concurrent chemoradiotherapy (CCRT…
Because of tumor metabolism and toxicities of therapy, many patients are faced with a high …

Results of concurrent radiotherapy and immunotherapy in recurrent and metastatic head and neck cancer: A single-center experience

SY Sari, MT Yilmaz, BY Aktas, S Aksoy, I Gullu… - Oral oncology, 2022 - Elsevier
… Our aim was to evaluate the results of concurrent stereotactic body radiotherapy (SBRT) …
cause of cancer-related death [1], [2]. The treatment of recurrent head and neck cancer (HNC) is …

IVIM-DWI and MRI-based radiomics in cervical cancer: prediction of concurrent chemoradiotherapy sensitivity in combination with clinical prognostic factors

Y Zhang, K Zhang, H Jia, B Xia, C Zang, Y Liu… - Magnetic Resonance …, 2022 - Elsevier
Cervical cancer is one of the most common gynecologic … insidious onset, most cervical cancer
patients are already at an … cervical cancer (LACC), concurrent chemoradiotherapy (CCRT) …

Global challenges of radiotherapy for the treatment of locally advanced cervical cancer

JS Mayadev, G Ke, U Mahantshetty… - … of Gynecologic Cancer, 2022 - ijgc.bmj.com
… use of radiotherapy in locally advanced cervical cancer (… effective radiotherapy use for
locally advanced cervical cancer. … years compared with concurrent chemoradiotherapy alone in …